Aspire Private Capital’s Zimmer Biomet ZBH Stock Holding History

Aspire Private Capital’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-5	Closed	-$540	–	665
2024 Q3	$540	Hold	5	–	–	﹤0.01%	615
2024 Q2	$543	Hold	5	–	–	﹤0.01%	629
2024 Q1	$660	Hold	5	–	–	﹤0.01%	649
2023 Q4	$608	Hold	5	–	–	﹤0.01%	633
2023 Q3	$561	Hold	5	–	–	﹤0.01%	634
2023 Q2	$728	Hold	5	–	–	﹤0.01%	594
2023 Q1	$646	Hold	5	–	–	﹤0.01%	592
2022 Q4	$638	Hold	5	–	–	﹤0.01%	582
2022 Q3	$1K	Hold	5	–	–	﹤0.01%	596
2022 Q2	$1K	Hold	5	–	–	﹤0.01%	586
2022 Q1	$1K	Hold	5	–	–	﹤0.01%	579
2021 Q4	$1K	Sell	5 -3,352	-100%	-$439K	﹤0.01%	615
2021 Q3	$477K	Buy	3,357 +132	+4%	+$19.4K	0.16%	87
2021 Q2	$504K	Buy	3,225 +1,013	+46%	+$164K	0.16%	87
2021 Q1	$344K	Buy	2,212 +2,207	+44,140%	+$342K	0.12%	99
2020 Q4	$1K	Hold	5	–	–	﹤0.01%	449
2020 Q3	$1K	Buy	+5	New	+$653	﹤0.01%	451
2020 Q1	–	Sell	-5	Closed	-$1K	–	500
2019 Q4	$1K	Hold	5	–	–	﹤0.01%	472
2019 Q3	$1K	Hold	5	–	–	﹤0.01%	446
2019 Q2	$1K	Hold	5	–	–	﹤0.01%	500
2019 Q1	$1K	Sell	5 -31	-86%	-$3.52K	﹤0.01%	534
2018 Q4	$4K	Buy	+36	New	+$4.05K	﹤0.01%	367

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Aspire Private Capital's ZBH Position: Q4 2024 in Review

Aspire Private Capital sold out of Zimmer Biomet (ZBH) in Q4 2024, closing a stake of 5 shares — an estimated $540 sold.

Aspire Private Capital first reported a position in ZBH in Q4 2018 and held it in 22 quarters. The position peaked at $504K in Q2 2021. 1,027 funds tracked by Wall St. Rank hold ZBH as of Q4 2024.

Aspire Private Capital reported no remaining Zimmer Biomet position as of Q4 2024 after selling out during the quarter.
Aspire Private Capital sold 5 Zimmer Biomet shares in Q4 2024, an estimated $540.
Aspire Private Capital first reported a position in Zimmer Biomet in Q4 2018 and held it in 22 quarters.
Aspire Private Capital's Zimmer Biomet position peaked at $504K in Q2 2021.
1,027 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2024.

Based on Aspire Private Capital's 13F filing for Q4 2024, filed 17 Jan 2025.